Patents for A61P 19 - Drugs for skeletal disorders (81,981)
01/2006
01/26/2006WO2006009464A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
01/26/2006WO2006009114A1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist
01/26/2006WO2006009092A1 Method of effectively using medicine and method concerning prevention of side effect
01/26/2006WO2006007780A1 Injectable bone-repairing bioactive material capable of forming gel and its preparation method
01/26/2006WO2005073236A3 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors
01/26/2006US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia
01/26/2006US20060020046 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
01/26/2006US20060020020 Regulators of the hedgehog pathway, compositions and uses related thereto
01/26/2006US20060020002 (3a alpha ,4 alpha ,7 alpha ,7a alpha )-Octahydro-3-hydroxy-2-[4-nitro-3-(trifluoromethyl)phenyl]-4,7-methano-1H-isoindol-1-one (2); steroid mimic; competitive inhibitors of intercellular ligand binding reactions involving CAMs and Leukointegrins; anticarcinogenic agent; autoimmune diseases
01/26/2006US20060019999 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain
01/26/2006US20060019984 Treatment of diseases with alpha-7nACh receptor full agonists
01/26/2006US20060019977 Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient
01/26/2006US20060019958 Immunity-related protein kinase inhibitors
01/26/2006US20060019945 Granzyme b inhibitors
01/26/2006US20060019930 Treatment and prevention of tissue damage
01/26/2006US20060019897 Anti-angiogenic polypeptides
01/26/2006US20060019886 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
01/26/2006US20060019392 Novel bone mineralization proteins, DNA, vectors, expression systems
01/26/2006US20060019294 Tyrosine kinase substrate (Tks) proteins
01/26/2006US20060018903 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease
01/26/2006US20060018892 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
01/26/2006DE102004031850A1 Substituirte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituirte tetrahydroisoquinolines as MMP inhibitors, to processes for their preparation and their use as a medicament
01/26/2006CA2573674A1 Muscarinic antagonists with parp and sir modulating activity as agents for inflammatory diseases
01/26/2006CA2571881A1 Heterocyclic derivatives for modulation of calcium channels
01/26/2006CA2570800A1 Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines
01/25/2006EP1619250A1 WSX receptor and ligands
01/25/2006EP1619205A1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
01/25/2006EP1619194A2 Triazaspiro[5.5]undecane derivatives and pharmaceutical composition comprising the same as active ingredient
01/25/2006EP1619193A1 Spiropiperidine compound and medicinal use thereof
01/25/2006EP1619189A1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives
01/25/2006EP1619180A1 CaSR ANTAGONIST
01/25/2006EP1618892A1 Instrument for inducing cytokine and method of inducing cytokine
01/25/2006EP1618884A1 Instrument for inducing cytokine and method of inducing cytokine
01/25/2006EP1618875A1 Composition for inhibition or prevention of bone density lowering and refreshment therefor
01/25/2006EP1618093A2 Indazole derivatives as jnk inhibitors
01/25/2006EP1617836A2 Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof
01/25/2006EP1617830A2 Esterified fatty acid composition
01/25/2006EP1372627B1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases
01/25/2006EP1235825B1 Novel benzoimidazole derivatives useful as antiproliferative agents
01/25/2006CN1726216A C-6 modified indazolylpyrrolotriazines
01/25/2006CN1724571A New saponin and its derivative, its preparation method and its use in medicine
01/25/2006CN1724561A Series peptide for promoting proliferation of bone marrow karyota and bone marrow substrate cell and its application
01/25/2006CN1724556A Oleanolic acid and its derivative, preparation method and use
01/25/2006CN1724536A Benzothiophene [32-b] indole kind derivative, its preparation method and use
01/25/2006CN1724520A Indenoindole ketone kind compound, its preparation method and use
01/25/2006CN1724021A Traditional Chinese medicine for treating rheumatoid disease
01/25/2006CN1724014A Extractive of total saponin of clematis root, prepn. method and pharmaceutical use thereof
01/25/2006CN1724013A Traditional Chinese medicinal prepn. for treating obstruction of qi in the chest
01/25/2006CN1724008A Traditional Chinese medicine
01/25/2006CN1723989A Extractive of kudzu, and its prepn. method and use
01/25/2006CN1723988A Medicinal composition contg. glucoside of pueravia flower and its application
01/25/2006CN1723976A Xianling gubao dripping pills having functions of reinforcing kidney strengthening bone, and its prepn method
01/25/2006CN1723966A Compound traditional Chinese medicine for treating fracture and injury, prepn. method and use thereof
01/25/2006CN1723959A Method for preparing medicine for treating cataclasis and soft tissue injury
01/25/2006CN1723935A Paste for removing obstruction in channels to relieve pain for treating osteoarthritis, and its prepn. method
01/25/2006CN1723932A Plaster for treating periarthritis of shoulder
01/25/2006CN1723924A Medicine for treating traumatic injury, and its prepn. method
01/25/2006CN1238363C Glucopyranosyloxypyrazole derivatives and use thereof in medicines
01/25/2006CN1238341C 1 Alpha-hydroxy-25-ene-vitamin D, analogs and use thereof
01/25/2006CN1238050C Traditional Chinese medicinal paste for treating arthralgia-syndrome and preparation method thereof
01/25/2006CN1238049C Traditional Chinese medicine paste for treating arthralgia-syndrome
01/25/2006CN1238048C Chinese traditional medicine for treating arthralgia -syndrome and its preparation
01/25/2006CN1238047C Adhesive plaster for treating arthralgia and formula
01/25/2006CN1238044C Chest bone fracture therapeutic oral medication
01/25/2006CN1238042C Shoulder pain treating Chinese medicine and its preparation process
01/25/2006CN1238025C Preparation method of traumatic injury bone-setting plaster
01/25/2006CN1238021C Medicine for treating hyperosteogeny
01/25/2006CN1238020C Medicine for treating waist and lower extremities pain
01/25/2006CN1238019C Oil for comforting channels and collaterals
01/25/2006CN1238018C Plaster for treating pain in neck, shoulder, waist and lower extremities
01/25/2006CN1238017C Preparation method of rheumatic osteodynia plaster
01/25/2006CN1238015C Adhesive plaster for treating traumatic injury pain
01/25/2006CN1238014C Adhesive medicated plaster for treating bone disease
01/25/2006CN1237993C Hyperosteogeny adhesive plaster and its preparation technology
01/25/2006CN1237987C Capsul for curing pain due to hyperosteogeny and osteoarthritis disease and its preparation method
01/24/2006US6989402 Thyroid receptor ligands and method II
01/24/2006US6989395 TNF inhibitors
01/24/2006US6989388 Antitumor agents; anticancer agents; antiischemic agents; antiinflamamtory agents
01/24/2006US6989385 Pyrazole compounds useful as protein kinase inhibitors
01/24/2006US6989368 Use of calmodulin to promote bone regeneration
01/24/2006US6989260 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders
01/24/2006US6989156 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated
01/24/2006US6989147 Tumor necrosis factor receptor protein for use in the treatment of arthritis
01/24/2006US6989146 Stress proteins and peptides and methods of use thereof
01/24/2006CA2100228C Phospholipid derivatives
01/19/2006WO2006006674A1 Pth-containing preparation for transmucosal administration
01/19/2006US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals
01/19/2006US20060014831 e.g. 2-[(2-methoxyphenyl)(1-naphthyl)methyl]malononitrile; antiinflammatory and hypoglycemic agent; rheumatoid arthritis, osteoarthritis, psoriatic and juvenile arthritis, inflammatory bowel disease, Crohn's disease, ulcerative and indeterminate colitis, psoriasis, asthma, hyperlipidemia
01/19/2006US20060014803 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
01/19/2006US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
01/19/2006US20060014781 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
01/19/2006US20060014780 Nicotinamide derivatives useful as PDE4 inhibitors
01/19/2006US20060014747 Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents
01/19/2006US20060014725 6-(1-benzyl-3-pentyl-1H-indol-2-yl)-1-bromo-2-naphthyl 1H-tetraazol-5-ylmethyl ether; useful in treating stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders
01/19/2006US20060014718 oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which by subsequent N-sulfation provides new epiK5-N,O-oversulfate-derivatives; free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field
01/19/2006US20060014701 Novel amide derivatives as growth hormone secretagogues
01/19/2006US20060014687 Bone delivery conjugates and method of using same to target proteins to bone
01/19/2006US20060013897 Compositions for cancer therapy saponins or sapogenins
01/19/2006US20060013877 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same
01/19/2006US20060013869 Electrospun amorphous pharmaceutical compositions